Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    11.00 (1.59%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Partial disposal - Besso Insurance Group

19 Mar 2012 12:07

RNS Number : 6124Z
B.P. Marsh & Partners PLC
19 March 2012
 

Date: 19th March 2012

On behalf of: B.P. Marsh & Partners Plc ("BP Marsh")

For immediate release

 

B.P. Marsh & Partners Plc

 

Partial disposal of shares

 

Besso Insurance Group Ltd ("Besso")

 

B P Marsh & Partners PLC, a niche venture capital provider to early stage financial services businesses, is pleased to announce the completion of the exercise of the Call Option that formed part of a transaction with Besso announced on 1st April 2011.

 

Under the terms of the transaction announced on 1st April 2011, BP Marsh's wholly owned subsidiary, B.P. Marsh & Company Limited, acquired an 11% stake in Besso (then known as Besso Holdings Ltd), increasing BP Marsh Group's combined holding to 34%. It was also agreed that B.P. Marsh & Company Limited would enter into a Call Option with Besso, allowing Besso the option to buy-back the equivalent of 4% of these shares at any point during the following 24 months.

 

The Call Option was accordingly exercised by Besso on 16th March 2012 in respect of the full 4%. Besso will cancel these shares upon buy-back and issue equivalent shares up to the same number to an employee incentive scheme. As a result of the Call Option being exercised, and a subsequent issue of the same amount of shares to management, BP Marsh's overall holding in Besso will stand at 30%.

 

The exercise price of the Call Option reflects the last published valuation of BP Marsh's holding in Besso at 31st July 2011 of £4.18m for 34%.

 

B.P Marsh & Company Limited has also agreed to provide Besso with a further £578,698 of loan funding in order to facilitate the exercise of the Call Option. This transaction therefore has no cash impact for BP Marsh.

 

BP Marsh supports Besso's aims of aligning senior management with shareholders by the exercise of the Option and believes that this will enable Besso to optimise opportunities for strategic growth and development.

 

 

 -

 

For further information:

 

B.P. Marsh & Partners Plc www.bpmarsh.co.uk

Brian Marsh OBE / Camilla Kenyon +44 (0)20 7233 3112

 

Nominated Adviser & Broker

Panmure Gordon

Paul Lumbis / Fred Walsh +44 (0)20 7459 3600

 

 

Notes to Editors:

 

About B.P. Marsh & Partners Plc

 

B.P. Marsh's current portfolio contains nine companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Over the past 20 years, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for at least four years.

 

Prior to Brian Marsh's involvement in the Company, he spent many years in insurance broking and underwriting in Lloyd's as well as the London and overseas market. He has over 30 years' experience in building, buying and selling financial services businesses, particularly in the insurance sector.

 

Jonathan Newman is a Chartered Management Accountant and is the Group Director of Finance and has over 14 years' experience in the financial services industry. Jonathan advises investee companies through three non-executive board appointments and evaluates new investment opportunities.

 

Daniel Topping is a Member of the Chartered Institute of Securities and Investment (MCSI) and an Associate Member of the Institute of Chartered Secretaries and Administrators (ACIS) having joined the Company in 2007. Dan was appointed director in 2011 and currently holds four non-executive board appointments through which he advises investee companies and he also evaluates new investment opportunities.

 

Camilla Kenyon was appointed as Head of Investor Relations at B. P. Marsh in February 2009, having four years prior experience with the Company. She holds two non-executive appointments and is Chair of the New Business Committee. She is a Member of the Investor Relations Society.

 

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISJLMTTMBMBBFT
Date   Source Headline
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:01 amRNSFinal Results for the Year to 31 January 2026
27th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSNotice of Results and Investor Presentation
24th Apr 20265:50 pmRNSTransaction in Own Shares
20th Apr 20265:25 pmRNSSIP Awards, PDMR Dealings, Treasury Shares, TVR
16th Apr 20267:00 amRNSDeferred Consideration Receipt & Special Dividend
14th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSFollow-on equity purchase in Pantheon
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20263:52 pmRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSNew Share Buyback Programme
18th Mar 20267:00 amRNSNew Investment: Nine Edge Wealth Limited
18th Mar 20267:00 amRNSNew Investment: Ventura Risk Partners Holdings
17th Mar 20264:48 pmRNSSale of Interest in Amiga to Sodalis
11th Mar 20267:00 amRNSUpdate on Sodalis Capital Limited
24th Feb 20267:00 amRNSTrading Update
6th Feb 20267:00 amRNSPurchase of Own Shares and Total Voting Rights
5th Feb 202611:44 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSInterim Dividend Declaration
18th Dec 20257:00 amRNSTransaction in Own Shares & Total Voting Rights
15th Dec 20257:00 amRNSSpecial Dividend Declaration
11th Dec 20257:00 amRNSAppointment of Nominated Adviser and Joint Brokers
2nd Dec 20257:00 amRNSChange in Executive Directorship Roles
27th Nov 20256:17 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSNew Investment: Sodalis Capital Limited
25th Nov 20254:55 pmRNSTransaction in Own Shares
24th Nov 20255:05 pmRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:57 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 202512:38 pmRNS-RB.P. Marsh to present at MelloLondon
11th Nov 20255:08 pmRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:01 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSSale of Stewart Specialty Risk Underwriting
27th Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSHalf-year Results
7th Oct 202511:15 amRNSNotice of HY Results and Investor Presentation
30th Sep 20253:52 pmRNSNew Investment: Oneglobal Broking Holdings Limited
23rd Sep 20257:00 amRNSTrading Update
22nd Sep 20253:23 pmRNSNew Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.